Mercury Laboratories Ltd.
BSE: 538964
₹796.00
₹0.00 (0.00%)As on 31-Jul-2026IST
Market cap
₹96 Cr
Revenue (TTM)
₹74 Cr
P/E Ratio
22.9
P/B Ratio
1.6
Div. Yield
0.4 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹4 Cr
-
ROE
6 %
-
ROCE
9.1 %
-
Industry P/E
38.04
-
EV/EBITDA
10
-
Debt to Equity
0.1
-
Book Value
₹486.5
-
EPS
₹37
-
Face value
10
-
Shares outstanding
1,200,000
10 Years Aggregate
CFO
₹45.59 Cr
EBITDA
₹70.66 Cr
Net Profit
₹37.98 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Mercury Lab
| -1.9 | -2.1 | 6.8 | -8.6 | -0.5 | 2.5 | 5.1 |
|
BSE Healthcare
| 17.0 | 3.6 | 13.8 | 10.8 | 22.3 | 14.2 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Mercury Lab
| -8.9 | -21.8 | 32.2 | 11.1 | 43.0 | 86.4 | -25.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Mercury Lab
|
796.0 | 95.5 | 73.8 | 4.2 | 6.2 | 7.8 | 22.9 | 1.6 |
| 2,098.8 | 12,828.9 | 1,479.1 | 198.6 | 18.6 | 30.3 | 64.5 | 17.2 | |
| 1,354.7 | 18,746.9 | 3,229.7 | 666.9 | 26.6 | 18.8 | 29.1 | 4.6 | |
| 230.8 | 1,519.3 | 293.9 | 45.5 | 17.7 | 17.8 | 33.4 | 6.1 | |
| 4,823.9 | 22,063.2 | 2,569.8 | 735.2 | 34.4 | 19.2 | 30 | 5.0 | |
| 885.3 | 1,969.7 | 272.0 | 36.1 | 19.4 | 11.5 | 54.6 | 5.9 | |
| 1,025.0 | 9,431.6 | 5,004.4 | 635.3 | 14.5 | 19.8 | 15.4 | 3.0 | |
| 1,990.5 | 4,77,311.7 | 59,910.5 | 12,172.7 | 23.8 | 15.7 | 39.5 | 5.7 | |
| 1,581.6 | 2,094.1 | 811.3 | 116.2 | 17.2 | 18.5 | 18 | 3.0 | |
| 44.5 | 271.8 | 44.6 | -2.5 | 0.8 | -2.6 | -- | 2.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Mercury Lab
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
1982
-
Chairman
Sanjay Patel
-
Managing Director
Rajendra R Shah
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Mercury Lab
What is the current share price of Mercury Laboratories Ltd Today?
The share price of Mercury Laboratories Ltd is ₹796.00 (BSE) as of 31-Jul-2026 IST. Mercury Laboratories Ltd has given a return of -0.46% in the last 3 years.
What is the current PB & PE ratio of Mercury Laboratories Ltd?
The P/E ratio of Mercury Laboratories Ltd is 22.95 times as on 31-Jul-2026, a 40 discount to its peers’ median range of 38.04 times.
The P/B ratio of Mercury Laboratories Ltd is 1.64 times as on 31-Jul-2026, a 67 discount to its peers’ median range of 4.99 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
31.25
|
1.83
|
|
2024
|
17.66
|
1.96
|
|
2023
|
12.59
|
1.54
|
|
2022
|
16.34
|
1.44
|
|
2021
|
14.45
|
2.09
|
What is the 52 Week High and Low of Mercury Laboratories Ltd?
The 52-week high and low of Mercury Laboratories Ltd are Rs 976.00 and Rs 620.55 as of 01-Aug-2026.
What is the market cap of Mercury Laboratories Ltd?
Mercury Laboratories Ltd has a market capitalisation of ₹ 96 Cr as on 31-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Mercury Laboratories Ltd?
Before investing in Mercury Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.